Inherited Hemophagocytic Lymphohistiocytosis (HLH)

Klinische Padiatrie

Volumn 222, Issue 6, 2010, Pages 345-350

  Schmid, Pachlopnik Jana ^a   Basile, G De Saint ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Fever; Genetic diseases; Hemophagocytic lymphohistiozytosis HLH; Hemophagocytosis; Immunodeficiency; Macrophage activation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; HYDROCORTISONE; MEMBRANE PROTEIN; METHOTREXATE; MUNC13 4 PROTEIN; MUNC18 2 PROTEIN; PERFORIN; RAB27A PROTEIN; STEROID; SYNTAXIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; MUNC18 PROTEIN; STX11 PROTEIN, HUMAN; STXBP2 PROTEIN, HUMAN; UNC13D PROTEIN, HUMAN;

ALLOGENEIC STEM CELL TRANSPLANTATION; AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW BIOPSY; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL VIABILITY; CLINICAL FEATURE; CYTOKINE STORM; CYTOTOXICITY; DEGRANULATION; DNA POLYMORPHISM; ERYTHROPHAGOCYTOSIS; FLOW CYTOMETRY; GENE MUTATION; GENETIC ANALYSIS; GRISCELLI SYNDROME; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MISSENSE MUTATION; NATURAL KILLER CELL; NEUTROPHIL COUNT; PATHOGENESIS; RETROSPECTIVE STUDY; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; CHILD; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; NUCLEOTIDE SEQUENCE; PROGNOSIS; VIRUS INFECTION;

CHILD; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; MEMBRANE PROTEINS; MUNC18 PROTEINS; PERFORIN; PROGNOSIS; QA-SNARE PROTEINS; VIRUS DISEASES;

EID: 78449292198     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1246165     Document Type: Review

References (53)

1. Badovinac VP, Hamilton SE, Harty JT. Viral infection results in massive CD8+ T-cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 2003 18 463-474
2. Barbosa MD, Nguyen QA, Tchernev VT, etal. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996 382 262-265
3. Behrens EM, Beukelman T, Paessler M, etal. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007 34 1133-1138
4. Binder D, van den Broek MF, Kagi D, etal. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T-cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med 1998 187 1903-1920
5. Bolitho P, Street SE, Westwood JA, etal. Perforin-mediated suppression of B-cell lymphoma. Proc Natl Acad Sci USA 2009 106 2723-2728
6. Bryceson YT, Rudd E, Zheng C, etal. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007 110 1906-1915
7. Cannella S, Santoro A, Bruno G, etal. Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma. Cancer 2007 109 2566-2571
8. Chia J, Yeo KP, Whisstock JC, etal. Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc Natl Acad Sci USA 2009 106 9809-9814
9. Clementi R, Locatelli F, Dupre L, etal. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 2005 105 4424-4428
10. Coffey AJ, Brooksbank RA, Brandau O, etal. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998 20 129-135
11. Côte M, Mnager MM, Burgess A, etal. Munc18-2/STXBP2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 (FHL5) and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 2009 119 in press.
12. de Saint Basile G, Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol 2001 13 549-554
13. Enders A, Zieger B, Schwarz K, etal. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 2006 108 81-87
14. Feldmann J, Callebaut I, Raposo G, etal. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003 115 461-473
15. Feldmann J, Le Deist F, Ouachee-Chardin M, etal. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol 2002 117 965-972
16. Haddad E, Sulis ML, Jabado N, etal. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997 89 794-800
17. Henter JI, Arico M, Egeler RM, etal. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997 28 342-347
18. Henter JI, Elinder G, Soder O, etal. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991 78 2918-2922
19. Henter JI, Elinder G, Soder O, etal. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991 80 428-435
20. Henter JI, Horne A, Arico M, etal. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007 48 124-131
21. Henter JI, Samuelsson-Horne A, Arico M, etal. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002 100 2367-2373
22. Horne A, Janka G, Maarten Egeler R, etal. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005 129 622-630
23. Horne A, Trottestam H, Arico M, etal. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol 2008 140 327-335
24. Jabado N, de Graeff-Meeder ER, Cavazzana-Calvo M, etal. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997 90 4743-4748
25. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr 2009 221 278-285
26. Jordan MB, Hildeman D, Kappler J, etal. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T-cells and interferon gamma are essential for the disorder. Blood 2004 104 735-743
27. Lipton JM, Westra S, Haverty CE, etal. Case records of the Massachusetts General Hospital, Weekly clinicopathological exercises. Case, 28-2004, Newborn, twins, with thrombocytopenia, coagulation defects, and hepatosplenomegaly. N Engl J Med 2004 351 1120-1130
28. Mahlaoui N, Ouachee-Chardin M, de Saint Basile G, etal. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics 2007 120 e622-e628
29. Malloy CA, Polinski C, Alkan S, etal. Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis. J Perinatol 2004 24 458-460
30. Mamishi S, Modarressi MH, Pourakbari B, etal. Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot. J Clin Immunol 2008 28 384-389
31. Mazodier K, Marin V, Novick D, etal. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005 106 3483-3489
32. Mehta PA, Davies SM, Kumar A, etal. Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Childrens Oncology Group. Leukemia 2006 20 1539-1541
33. Menager MM, Menasche G, Romao M, etal. Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4. Nat Immunol 2007 8 257-267
34. Menasche G, Fischer A, de Saint Basile G. Griscelli syndrome types 1 and 2. Am J Hum Genet 2002 71 1237-1238 author reply 1238.
35. Menasche G, Ho CH, Sanal O, etal. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003 112 450-456
36. Menasche G, Pastural E, Feldmann J, etal. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000 25 173-176
37. Milone MC, Tsai DE, Hodinka RL, etal. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 2005 105 994-996
38. Nagasawa M, Yi Z, Imashuku S, etal. Soluble TWEAK is markedly elevated in hemophagocytic lymphohistiocytosis. Am J Hematol 2008 83 222-225
39. Nagle DL, Karim MA, Woolf EA, etal. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996 14 307-311
40. Osugi Y, Hara J, Tagawa S, etal. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997 89 4100-4103
41. Pachlopnik Schmid J, Ho CH, Chretien F, etal. Neutralization of IFN defeats hemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med in press 2009a
42. Pachlopnik Schmid J, Moshous D, Boddaert N, etal. Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. Blood 2009b 114 211-218
43. Parolini S, Bottino C, Falco M, etal. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000 192 337-346
44. Rigaud S, Fondaneche MC, Lambert N. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006 444 110-114
45. Santoro A, Cannella S, Trizzino A, etal. A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica 2005 90 697-698
46. Smyth MJ, Thia KY, Street SE, etal. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000 192 755-760
47. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, etal. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999 286 1957-1959
48. Suzuki N, Morimoto A, Ohga S, etal. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. 2009 155 235.e1-238.e1
49. Torrents D, Mykkanen J, Pineda M, etal. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet 1999 21 293-296
50. Ueda I, Ishii E, Morimoto A, etal. Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 2006 46 482-488
51. Voskoboinik I, Sutton VR, Ciccone A, etal. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 2007 110 1184-1190
52. zur Stadt U, Rohr J, Seifert W, etal. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009 85 482-492
53. zur Stadt U, Schmidt S, Kasper B, etal. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005 14 827-834